Clinically reviewed by Dr. Sarah Boss, MD
New suicidal thoughts, marked agitation or severe mood change needs prompt assessment. Do not use alcohol or borrowed sedatives to manage social situations. Fainting, serious breathing difficulty, a seizure or collapse requires urgent medical care.
Medication may help some adults with social anxiety disorder, but the goal is not to turn an introverted person into an extrovert. Treatment aims to reduce disabling fear, avoidance and the restriction of everyday life. Persistent social anxiety, occasional presentation nerves and a co-occurring depressive disorder are different treatment questions. A useful medication plan identifies which problem is being addressed and how it connects with psychological care.
Recognizing the problem that needs treatment
Social anxiety disorder involves substantial fear of scrutiny, embarrassment or negative judgment in social situations. It may affect speaking, eating around others, work meetings, education, dating or asking for help. Some people have predominantly performance-related fears; others experience difficulties across many situations. Ordinary shyness or a preference for solitude is not by itself a disorder. [1]
Assessment should consider persistence, avoidance, distress and functional impact, together with depression, other anxiety disorders, neurodevelopmental needs and substance use. Explain what you avoid and what it costs you, rather than trying to perform confidence during the appointment. The treatment target should reflect the person’s priorities, not someone else’s preferred personality.
Why individual CBT is central
NICE recommends individual cognitive behavioral therapy developed specifically for social anxiety as an initial adult treatment. It works on processes such as fear of evaluation, self-focused attention, avoidance and unhelpful safety behaviors. Medication can reduce symptoms, but it does not automatically change all the learned ways a person manages social situations. [2]
Ask whether the proposed therapy follows an approach designed for social anxiety rather than relying only on general supportive conversation. Discuss practical barriers, preferences and previous experiences. A medicine may be considered when preferred or when psychological treatment has not provided enough benefit, but choosing medication should not remove access to appropriate therapy.
SSRIs used when medication is chosen
For adults choosing pharmacological treatment, NICE names escitalopram or sertraline as initial SSRI options. The actual product license and local prescribing guidance should still be checked. An antidepressant prescription does not imply that social anxiety is being treated as a personality flaw or that depression must also be present. [2]
Choice should account for previous response, other medicines, physical health, adverse effects and personal priorities. Someone particularly concerned about sexual function or sleep may want those issues discussed before treatment begins. Another person may need help with reliable administration or a formulation they can swallow. These practical differences can matter more than a generic ranking of SSRIs.
Expectations during the first part of treatment
SSRIs are usually taken consistently rather than only before a difficult event. Improvement develops over time, while nausea, headache, agitation or sleep changes may appear earlier. The NHS identifies antidepressants as one treatment option alongside CBT and guided self-help, not as an immediate confidence-producing medicine. [3]
Agree when early tolerability will be checked and when the overall response will be reviewed. A short symptom record can help, but a person should not need to rate every conversation. Focus on a few meaningful situations, such as attending a meeting, making a necessary call or staying at a social event. Report severe or persistent adverse effects rather than assuming they must be endured.
What a partial response may mean
A medicine may reduce the intensity of anxiety while avoidance remains. That does not automatically call for a higher dose. Discuss whether targeted CBT, practical support or another adjustment is needed. Likewise, feeling less nervous without returning to any valued activities may be an incomplete outcome rather than full recovery.
When initial treatment has not been enough, review the trial length, actual use, side effects and whether other conditions are influencing symptoms. NICE describes adding individual CBT after a partial medication response and considering alternative medicines when an initial SSRI is ineffective or poorly tolerated. This is a structured treatment pathway, not an instruction to cycle through prescriptions independently. [2]
Later medication options and specialist decisions
Alternatives in relevant adult pathways can include another SSRI, such as paroxetine or fluvoxamine, or the SNRI venlafaxine. Some uses are off-label in particular jurisdictions. The individual profiles for paroxetine and venlafaxine explain why withdrawal history and interactions matter when choosing or changing treatment.
After further unsuccessful treatment, an MAO inhibitor such as moclobemide or phenelzine may enter a specialist discussion. These medicines have important interaction and, depending on the product, dietary precautions. A recommendation from an older guideline does not replace checking current product information. Do not combine them with an SSRI or plan a washout period from a general internet table. [2]
Performance anxiety and beta blockers
Beta blockers may reduce physical symptoms such as a rapid heart rate or tremor in selected performance situations. That is a narrower aim than treating persistent fear of judgment across everyday life. NIMH discusses this distinction in its social-anxiety information. A reduction in shaking should not be presented as proof that the full disorder has been treated. [1]
Propranolol has its own precautions, including concerns in people with particular breathing, heart-rate or blood-pressure problems. It should not be borrowed for an interview or used to test whether an unexplained physical symptom is anxiety. Discuss the actual situation and medical history with the clinician instead of treating it as a risk-free confidence aid.
Benzodiazepines are not a routine long-term solution
Benzodiazepines can rapidly reduce anxiety, but sedation, memory effects, tolerance and dependence limit their role. NICE does not routinely recommend them for adult social anxiety. US patient information describes possible brief use while warning about dependence. The prescribing context matters, and a short-term effect should not be confused with a sustainable treatment for avoidance. [2] [1]
A person already taking one regularly needs a review, not abrupt discontinuation. Tell the clinician if the medicine is increasingly required to enter ordinary situations, if doses are escalating or if alcohol is also being used. These patterns deserve support and a coordinated plan rather than blame or a sudden withdrawal of care.
Side effects, interactions and monitoring
Antidepressants can cause digestive changes, headache, sleep problems, sweating and sexual difficulties. The exact medicine may also have blood-pressure, heart-rhythm or other precautions. Bring all medicines, supplements and occasional products to a pharmacist review, including pain and sleep treatments. Common use does not make a combination automatically safe.
New suicidal thoughts, severe restlessness, marked agitation or unusually elevated mood needs prompt assessment. A seizure, collapse, severe allergic reaction or fever with confusion and pronounced muscle stiffness requires urgent medical help. Discuss pregnancy plans, breastfeeding and relevant physical illness before changes. Treatment should consider both the medicine’s risks and the impact of untreated anxiety.
Alcohol and other substances used to cope socially
Some people drink or use other substances to make social situations feel manageable. That can complicate assessment, sleep, mood and medication safety. Explain the amount, timing and purpose of use, including substances taken before an event and those used afterward to settle down. Social anxiety and a substance-use disorder can coexist and may both need treatment.
Do not combine alcohol with a borrowed benzodiazepine or increase a sedative because an event feels especially important. A psychiatric prescription is not protection against intoxication or overdose. If physical dependence on alcohol or sedatives is possible, seek clinical advice before a major reduction. The alcohol and psychiatric medicines guide explains relevant interaction concerns.
Withdrawal and continuing care
Stopping an antidepressant can produce symptoms that overlap with anxiety, including disturbed sleep and physical discomfort. Paroxetine and venlafaxine require particular attention to withdrawal planning, but an individualized approach is important with other drugs too. Do not interpret every symptom after a change as proof that social anxiety has permanently returned.
Discuss the reason for stopping, the reduction plan, the monitoring and ongoing psychological support. A planned change should account for previous withdrawal experience and current life circumstances without promising a symptom-free process. The withdrawal-or-relapse guide explains why timing and the whole clinical picture matter.
Children and young people
Adult prescribing guidance should not be applied directly to a child. NICE does not routinely recommend pharmacological treatment for social anxiety in children and young people, emphasizing appropriate psychological interventions. A separate co-occurring disorder may require its own assessment and treatment, but that is not the same as using the adult social-anxiety pathway. [2]
Families can help describe school attendance, friendships and avoidance while listening to the young person’s account. The plan should explain how support is coordinated and how concerns can be raised without turning ordinary social participation into a series of tests. Any proposed medicine should have a clearly stated indication and monitoring arrangements.
Preparing for a review when asking for help is difficult
The condition itself may make appointments feel threatening. Write down the main difficulty and the most important question before the visit. Ask whether notes can be used, whether a supporter may attend and how follow-up can be arranged. A concise description of actual avoidance is more helpful than trying to appear completely composed.
Choose goals that reflect what matters to you: asking a question at work, meeting a friend, eating with others or pursuing an opportunity. Review whether treatment is expanding these choices without an unacceptable burden of adverse effects. The medication-review checklist can help connect medicine decisions with meaningful daily outcomes.
Frequently asked questions
Is medication intended to change my personality?
No. The aim is to reduce disabling anxiety and avoidance, not to impose a particular social style. Preferences for quiet or solitude should not automatically be treated as symptoms.
Can an SSRI be taken only before a presentation?
That is not its usual role in social-anxiety treatment. SSRIs are generally taken consistently and assessed over time. Performance-specific questions need their own clinical discussion.
Does less shaking mean the disorder is resolved?
Not necessarily. Physical symptoms, fear of judgment, avoidance and functioning should be considered together. A symptom-targeted medicine may not address all these areas.
What is the next step if medication partly helps?
Review the response and consider whether targeted CBT, a different medicine or another adjustment is appropriate. Do not increase, combine or switch treatments without a coordinated plan.
